RN Mobile Menu


Rheumatology Network

How well does belimumab work in your lupus patients?

Research shows that belimumab is working in lupus. Learn more and share your story during Thursday's #RheumJC Twitter chat. (Pictured here is IgG1 monoclonal antibody, the basis for belimumab. @molekuul.be/Shutterstock.com)

Recent Content

Eric Morand, M.D., PhD.

Eric Morand, M.D., Ph.D., Director of Rheumatology at Monash Health in Australia, speaks with Rheumatology Network about his recent article in Nature Reviews Rheumatology.


Study shows that 14-3-3η protein serum levels can more accurately identify patients with early polyarthritis at risk for long-term poor outcomes.

In 2015, ACR and EULAR issued classification criteria for gout. The scoring system is summarized here in an easy to use format for physicians and patients.


Few gout patients know their serum urate goals, which researchers say could hinder their chances of reaching remission.

Seth Lederman M.D.

Profiles in Rheumatology: Seth Lederman, M.D., chairman and CEO of Tonix Pharmaceuticals

A new study recommends that only a small minority of rheumatoid arthritis patients who are in clinical remission should discontinue adalimumab.

Biosimilar CT-P13 may offer an effective option to infliximab for ankylosing spondylitis.

By clicking Accept, you agree to become a member of the UBM Medica Community.